WSTAM
NTUS

Wilbanks Smith & Thomas Asset Management’s Natus Medical Inc NTUS Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-40
Closed -$1K – 1425
2018
Q3 		$1K Buy
+40
New +$1.41K ﹤0.01% 1578

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's NTUS Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of Natus Medical Inc (NTUS) in Q4 2018, closing a stake of 40 shares — an estimated $1K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in NTUS in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 174 funds tracked by Wall St. Rank hold NTUS as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Natus Medical Inc position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 40 Natus Medical Inc shares in Q4 2018, an estimated $1K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Natus Medical Inc in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Natus Medical Inc position peaked at $1K in Q3 2018.
  • 174 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.